Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Radiodermatitis 1Breast Neoplasms 1

Interventions

Low-Level Light Therapy 6Standard of Care 5Petrolatum 3Norepinephrine 3triethanolamine 2sapropterin 2Sodium Chloride 2Radiotherapy 2Curcumin 2Biafine 2eucerin 1epigallocatechin gallate 1dimethicone 1cetyl alcohol, propylene glycol, sodium lauryl sulfate non-lipid cleansing lotion 1calcipotriene 1Zinc Oxide 1Triamcinolone Acetonide 1Thioctic Acid 1Sodium Hypochlorite 1Silver Sulfadiazine 1Radiotherapy, Conformal 1Practice Guidelines as Topic 1Melatonin 1Laser Therapy 1Hydrogel, Polyethylene Glycol Dimethacrylate 1Hydrocortisone 1Gels 1Dimethyl Sulfoxide 1Centella asiatica extract 1Catechin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Radiodermatitis × Hydrogel, Polyethylene Glycol Dimethacrylate × Clear all
NCT05073172 2024-05-06

StrataXRT for the Prevention and Treatment of Radiation Dermatitis in Breast Cancer or Head and Neck Cancer Patients

OHSU Knight Cancer Institute

Phase NA Withdrawn
Breast

Breast Neoplasms, Radiodermatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡